PD-Rx Pharmaceuticals Incorporated Ibuprofen 200 mg tablets a) 24 tablets NDC 55289-673-24; b) 30...

FDA Drug Recall #D-0341-2018 — Class II — January 25, 2018

Recall Summary

Recall Number D-0341-2018
Classification Class II — Moderate risk
Date Initiated January 25, 2018
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm PD-Rx Pharmaceuticals, Inc.
Location Oklahoma City, OK
Product Type Drugs
Quantity 7174 bottles

Product Description

PD-Rx Pharmaceuticals Incorporated Ibuprofen 200 mg tablets a) 24 tablets NDC 55289-673-24; b) 30 tablets NDC 55289-673-30; c) 50 tablets NDC 55289-673-50; d) 60 tablets NDC 55289-673-60

Reason for Recall

CGMP deviations.

Distribution Pattern

Nationwide

Lot / Code Information

Lots: K16E92 Exp. 5/31/18; B17A87 Exp. 5/31/18; E17A51 Exp. 5/31/18; L16B59 Exp. 1/31/18; K16E01 Exp. 5/31/18; A17F21 Exp. 5/31/18; B17D71 Exp. 5/31/18; D17E92 Exp. 5/31/18; J16D13 Exp. 1/31/18; A17D63 Exp. 5/31/18; E17A18 Exp. 5/31/18; F17B87 Exp. 5/31/18; C17C58 Exp. 5/31/18

Other Recalls from PD-Rx Pharmaceuticals, Inc.

Recall # Classification Product Date
D-0163-2025 Class II DULoxetine DR USP, 30 mg, 90-count bottle, Rx O... Dec 4, 2024
D-0558-2023 Class II Simvastatin USP, 10 mg, Rx only, Intas Pharm, L... Apr 6, 2023
D-0559-2023 Class II Glimepiride USP, 4 mg, 90 count-bottles, Rx onl... Apr 6, 2023
D-0560-2023 Class II Simvastatin USP 20 mg, Rx only, Intas Pharm. Li... Apr 6, 2023
D-0557-2023 Class II Montelukast Sodium USP, 10 mg, 30 count-bottles... Apr 6, 2023

Frequently Asked Questions

cGMP stands for Current Good Manufacturing Practice — the FDA's regulations governing drug manufacturing quality. A cGMP recall means the company failed to follow required manufacturing standards. This could involve inadequate testing, poor environmental controls, documentation failures, or process deviations. cGMP recalls do not always mean the product is directly harmful — in many cases, quality records are insufficient to confirm the product meets specifications. However, the FDA requires a recall because without proper documentation, product quality cannot be assured. These are often Class II or Class III recalls.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.